市場調査レポート

商品コード

1749704

メディカルライティング向けAIの世界市場：種類別・展開方式別・最終用途別・地域別の評価、機会と予測 (2018～2032年)

Global AI in Medical Writing Market Assessment, By Type, By Deployment Mode, By End-use, By Region, Opportunities and Forecast, 2018-2032F

出版日: 2025年06月17日
発行: Market Xcel - Markets and Data
ページ情報: 英文 242 Pages
納期: 3～5営業日

カスタマイズ可能

価格

PDF & Excel Printable (Single User License)

USD 4,800 702,480円

レポートPDFを1名の方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Corporate License)

USD 6,000 878,100円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能ですが、企業内部での利用に限定されます。ご利用に際しては、あらかじめ出版社の許諾を得る必要があります。詳細はお問合せください。印刷は可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Custom Research License)

USD 8,500 1,243,975円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。アナリストアワー100時間が含まれており、レポートのカスタマイズなどにご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.35円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界のメディカルライティング向けAI市場は、2025～2032年の予測期間中にCAGR 11.61％を記録し、2024年の8億4,542万米ドルから2032年には20億3,505万米ドルに成長すると予測されています。市場の成長は、規制文書、科学出版物、臨床研究の増加、生成AIへの依存の高まり、反復作業を合理化し、ヒューマンエラーの発生を減らすために、さまざまな医療プロセスへの新技術の組み込みへの注目の高まりに起因している可能性があります。

世界中の規制当局は、人の手によるレビューが維持され、監査証跡が保存されることを条件に、AIによる文書化に徐々に寛容になってきています。AIはまた、提出書類のセクション間の一貫性を確保し、複数の著者が関与している場合でも、チームが文書の整合性を維持するのを支援します。臨床文書作成のためのプラグアンドプレイ・ソリューションを提供するAIプラットフォームが利用可能になりつつあることで、ライティングチームを拡大することなく厳しい期限に対応する必要がある中規模のCROや製薬企業での採用が加速しています。電子データ収集（EDC）や臨床試験マスターファイル（TMF）システムと統合されたAIツールを使用することで、企業はソースから提出までのデータの流れを自動化することができます。

メディカルライティングにおけるさまざまなAIツールの認知度と受容度が高まっているため、世界中のAI企業は調査支援を提供する新モデルの立ち上げに注力し、科学的コンテンツ作成のワークフローを変革しつつあります。例えば、2024年11月、AINGENS, LLCは、引用サポート、編集、参考文献管理を提供するAI搭載のメディカルライティングツールであるMACg（Medical Affairs Content Generator）を発表しました。

市場規模の分析と予測
- 金額ベース
市場シェアの分析と予測
- 種類別
  - 臨床文書作成
  - 規制文書作成
  - 患者記録
  - 科学論文執筆
- 展開方式別
  - オンプレミス
  - クラウドベース
- 最終用途別
  - 医療機器企業
  - 製薬・バイオテクノロジー企業
  - 学術研究機関
  - その他
- 地域別
  - 北米
  - 欧州
  - アジア太平洋
  - 南米
  - 中東・アフリカ
- 市場シェア分析：企業別（上位5社およびその他、金額ベース、2024年）
市場マップ分析（2024年）
- 種類別
- 展開方式別
- 最終用途別
- 地域別

第6章北米のメディカルライティング向けAI市場の将来展望 (2018～2032年)

市場規模の分析と予測
- 金額ベース
市場シェアの分析と予測
- 種類別
  - 臨床文書作成
  - 規制文書作成
  - 患者記録
  - 科学論文執筆
- 展開方式別
  - オンプレミス
  - クラウドベース
- 最終用途別
  - 医療機器企業
  - 製薬・バイオテクノロジー企業
  - 学術研究機関
  - その他
- 国別シェア
  - 米国
  - カナダ
  - メキシコ
国別の市場評価
- 米国のメディカルライティング向けAI市場の展望（2018～2032年）*
  - 市場規模の分析と予測
  - 市場シェアの分析と予測
- カナダ
- メキシコ

すべてのセグメントは、対象となるすべての地域と国に提供されます。

第7章欧州のメディカルライティング向けAI市場の将来展望 (2018～2032年)

ドイツ
フランス
イタリア
英国
ロシア
オランダ
スペイン
トルコ
ポーランド

第8章アジア太平洋のメディカルライティング向けAI市場の将来展望 (2018～2032年)

インド
中国
日本
オーストラリア
ベトナム
韓国
インドネシア
フィリピン

第9章南米のメディカルライティング向けAI市場の将来展望 (2018～2032年)

ブラジル
アルゼンチン

第10章中東・アフリカのメディカルライティング向けAI市場の将来展望 (2018～2032年)

サウジアラビア
アラブ首長国連邦
南アフリカ

第11章需要・供給分析

第12章ポーターのファイブフォース分析

第13章 PESTLE分析

第14章価格分析

第15章市場力学

市場促進要因
市場の課題

第16章市場の動向と発展

第17章技術進歩とイノベーション

第18章ケーススタディ

第19章競合情勢

市場リーダー上位5社：競合マトリックス
SWOT分析：上位5社
主要企業の情勢：上位10社
- Indegene Inc.
- Suki AI, Inc.
- Certara, Inc.
- Abridge Al, Inc.
- Freyr Software Services Pvt Ltd
- IQVIA Inc.
- GENINVO
- Teladoc Health, Inc.
- TrialAssure
- Yseop SAS

上記企業は市場シェア順ではなく、分析作業中に入手した情報に従って変更される可能性があります。

第20章戦略提言

第21章 Market Xcelについて、免責事項

図表

List of Tables

Table 1. Competition Matrix of Top 5 Market Leaders
Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

Figure 1. Global AI in Medical Writing Market, By Value, In USD Million, 2018-2032F
Figure 2. Global AI in Medical Writing Market Share (%), By Type, 2018-2032F
Figure 3. Global AI in Medical Writing Market Share (%), By Deployment Mode, 2018-2032F
Figure 4. Global AI in Medical Writing Market Share (%), By End-use, 2018-2032F
Figure 5. Global AI in Medical Writing Market Share (%), By Region, 2018-2032F
Figure 6. North America AI in Medical Writing Market, By Value, In USD Million, 2018-2032F
Figure 7. North America AI in Medical Writing Market Share (%), By Type, 2018-2032F
Figure 8. North America AI in Medical Writing Market Share (%), By Deployment Mode, 2018-2032F
Figure 9. North America AI in Medical Writing Market Share (%), By End-use, 2018-2032F
Figure 10. North America AI in Medical Writing Market Share (%), By Country, 2018-2032F
Figure 11. United States AI in Medical Writing Market, By Value, In USD Million, 2018-2032F
Figure 12. United States AI in Medical Writing Market Share (%), By Type, 2018-2032F
Figure 13. United States AI in Medical Writing Market Share (%), By Deployment Mode, 2018-2032F
Figure 14. United States AI in Medical Writing Market Share (%), By End-use, 2018-2032F
Figure 15. Canada AI in Medical Writing Market, By Value, In USD Million, 2018-2032F
Figure 16. Canada AI in Medical Writing Market Share (%), By Type, 2018-2032F
Figure 17. Canada AI in Medical Writing Market Share (%), By Deployment Mode, 2018-2032F
Figure 18. Canada AI in Medical Writing Market Share (%), By End-use, 2018-2032F
Figure 19. Mexico AI in Medical Writing Market, By Value, In USD Million, 2018-2032F
Figure 20. Mexico AI in Medical Writing Market Share (%), By Type, 2018-2032F
Figure 21. Mexico AI in Medical Writing Market Share (%), By Deployment Mode, 2018-2032F
Figure 22. Mexico AI in Medical Writing Market Share (%), By End-use, 2018-2032F
Figure 23. Europe AI in Medical Writing Market, By Value, In USD Million, 2018-2032F
Figure 24. Europe AI in Medical Writing Market Share (%), By Type, 2018-2032F
Figure 25. Europe AI in Medical Writing Market Share (%), By Deployment Mode, 2018-2032F
Figure 26. Europe AI in Medical Writing Market Share (%), By End-use, 2018-2032F
Figure 27. Europe AI in Medical Writing Market Share (%), By Country, 2018-2032F
Figure 28. Germany AI in Medical Writing Market, By Value, In USD Million, 2018-2032F
Figure 29. Germany AI in Medical Writing Market Share (%), By Type, 2018-2032F
Figure 30. Germany AI in Medical Writing Market Share (%), By Deployment Mode, 2018-2032F
Figure 31. Germany AI in Medical Writing Market Share (%), By End-use, 2018-2032F
Figure 32. France AI in Medical Writing Market, By Value, In USD Million, 2018-2032F
Figure 33. France AI in Medical Writing Market Share (%), By Type, 2018-2032F
Figure 34. France AI in Medical Writing Market Share (%), By Deployment Mode, 2018-2032F
Figure 35. France AI in Medical Writing Market Share (%), By End-use, 2018-2032F
Figure 36. Italy AI in Medical Writing Market, By Value, In USD Million, 2018-2032F
Figure 37. Italy AI in Medical Writing Market Share (%), By Type, 2018-2032F
Figure 38. Italy AI in Medical Writing Market Share (%), By Deployment Mode, 2018-2032F
Figure 39. Italy AI in Medical Writing Market Share (%), By End-use, 2018-2032F
Figure 40. United Kingdom AI in Medical Writing Market, By Value, In USD Million, 2018-2032F
Figure 41. United Kingdom AI in Medical Writing Market Share (%), By Type, 2018-2032F
Figure 42. United Kingdom AI in Medical Writing Market Share (%), By Deployment Mode, 2018-2032F
Figure 43. United Kingdom AI in Medical Writing Market Share (%), By End-use, 2018-2032F
Figure 44. Russia AI in Medical Writing Market, By Value, In USD Million, 2018-2032F
Figure 45. Russia AI in Medical Writing Market Share (%), By Type, 2018-2032F
Figure 46. Russia AI in Medical Writing Market Share (%), By Deployment Mode, 2018-2032F
Figure 47. Russia AI in Medical Writing Market Share (%), By End-use, 2018-2032F
Figure 48. Netherlands AI in Medical Writing Market, By Value, In USD Million, 2018-2032F
Figure 49. Netherlands AI in Medical Writing Market Share (%), By Type, 2018-2032F
Figure 50. Netherlands AI in Medical Writing Market Share (%), By Deployment Mode, 2018-2032F
Figure 51. Netherlands AI in Medical Writing Market Share (%), By End-use, 2018-2032F
Figure 52. Spain AI in Medical Writing Market, By Value, In USD Million, 2018-2032F
Figure 53. Spain AI in Medical Writing Market Share (%), By Type, 2018-2032F
Figure 54. Spain AI in Medical Writing Market Share (%), By Deployment Mode, 2018-2032F
Figure 55. Spain AI in Medical Writing Market Share (%), By End-use, 2018-2032F
Figure 56. Turkey AI in Medical Writing Market, By Value, In USD Million, 2018-2032F
Figure 57. Turkey AI in Medical Writing Market Share (%), By Type, 2018-2032F
Figure 58. Turkey AI in Medical Writing Market Share (%), By Deployment Mode, 2018-2032F
Figure 59. Turkey AI in Medical Writing Market Share (%), By End-use, 2018-2032F
Figure 60. Poland AI in Medical Writing Market, By Value, In USD Million, 2018-2032F
Figure 61. Poland AI in Medical Writing Market Share (%), By Type, 2018-2032F
Figure 62. Poland AI in Medical Writing Market Share (%), By Deployment Mode, 2018-2032F
Figure 63. Poland AI in Medical Writing Market Share (%), By End-use, 2018-2032F
Figure 64. South America AI in Medical Writing Market, By Value, In USD Million, 2018-2032F
Figure 65. South America AI in Medical Writing Market Share (%), By Type, 2018-2032F
Figure 66. South America AI in Medical Writing Market Share (%), By Deployment Mode, 2018-2032F
Figure 67. South America AI in Medical Writing Market Share (%), By End-use, 2018-2032F
Figure 68. South America AI in Medical Writing Market Share (%), By Country, 2018-2032F
Figure 69. Brazil AI in Medical Writing Market, By Value, In USD Million, 2018-2032F
Figure 70. Brazil AI in Medical Writing Market Share (%), By Type, 2018-2032F
Figure 71. Brazil AI in Medical Writing Market Share (%), By Deployment Mode, 2018-2032F
Figure 72. Brazil AI in Medical Writing Market Share (%), By End-use, 2018-2032F
Figure 73. Argentina AI in Medical Writing Market, By Value, In USD Million, 2018-2032F
Figure 74. Argentina AI in Medical Writing Market Share (%), By Type, 2018-2032F
Figure 75. Argentina AI in Medical Writing Market Share (%), By Deployment Mode, 2018-2032F
Figure 76. Argentina AI in Medical Writing Market Share (%), By End-use, 2018-2032F
Figure 77. Asia-Pacific AI in Medical Writing Market, By Value, In USD Million, 2018-2032F
Figure 78. Asia-Pacific AI in Medical Writing Market Share (%), By Type, 2018-2032F
Figure 79. Asia-Pacific AI in Medical Writing Market Share (%), By Deployment Mode, 2018-2032F
Figure 80. Asia-Pacific AI in Medical Writing Market Share (%), By End-use, 2018-2032F
Figure 81. Asia-Pacific AI in Medical Writing Market Share (%), By Country, 2018-2032F
Figure 82. India AI in Medical Writing Market, By Value, In USD Million, 2018-2032F
Figure 83. India AI in Medical Writing Market Share (%), By Type, 2018-2032F
Figure 84. India AI in Medical Writing Market Share (%), By Deployment Mode, 2018-2032F
Figure 85. India AI in Medical Writing Market Share (%), By End-use, 2018-2032F
Figure 86. China AI in Medical Writing Market, By Value, In USD Million, 2018-2032F
Figure 87. China AI in Medical Writing Market Share (%), By Type, 2018-2032F
Figure 88. China AI in Medical Writing Market Share (%), By Deployment Mode, 2018-2032F
Figure 89. China AI in Medical Writing Market Share (%), By End-use, 2018-2032F
Figure 90. Japan AI in Medical Writing Market, By Value, In USD Million, 2018-2032F
Figure 91. Japan AI in Medical Writing Market Share (%), By Type, 2018-2032F
Figure 92. Japan AI in Medical Writing Market Share (%), By Deployment Mode, 2018-2032F
Figure 93. Japan AI in Medical Writing Market Share (%), By End-use, 2018-2032F
Figure 94. Australia AI in Medical Writing Market, By Value, In USD Million, 2018-2032F
Figure 95. Australia AI in Medical Writing Market Share (%), By Type, 2018-2032F
Figure 96. Australia AI in Medical Writing Market Share (%), By Deployment Mode, 2018-2032F
Figure 97. Australia AI in Medical Writing Market Share (%), By End-use, 2018-2032F
Figure 98. Vietnam AI in Medical Writing Market, By Value, In USD Million, 2018-2032F
Figure 99. Vietnam AI in Medical Writing Market Share (%), By Type, 2018-2032F
Figure 100. Vietnam AI in Medical Writing Market Share (%), By Deployment Mode, 2018-2032F
Figure 101. Vietnam AI in Medical Writing Market Share (%), By End-use, 2018-2032F
Figure 102. South Korea AI in Medical Writing Market, By Value, In USD Million, 2018-2032F
Figure 103. South Korea AI in Medical Writing Market Share (%), By Type, 2018-2032F
Figure 104. South Korea AI in Medical Writing Market Share (%), By Deployment Mode, 2018-2032F
Figure 105. South Korea AI in Medical Writing Market Share (%), By End-use, 2018-2032F
Figure 106. Indonesia AI in Medical Writing Market, By Value, In USD Million, 2018-2032F
Figure 107. Indonesia AI in Medical Writing Market Share (%), By Type, 2018-2032F
Figure 108. Indonesia AI in Medical Writing Market Share (%), By Deployment Mode, 2018-2032F
Figure 109. Indonesia AI in Medical Writing Market Share (%), By End-use, 2018-2032F
Figure 110. Philippines AI in Medical Writing Market, By Value, In USD Million, 2018-2032F
Figure 111. Philippines AI in Medical Writing Market Share (%), By Type, 2018-2032F
Figure 112. Philippines AI in Medical Writing Market Share (%), By Deployment Mode, 2018-2032F
Figure 113. Philippines AI in Medical Writing Market Share (%), By End-use, 2018-2032F
Figure 114. Middle East & Africa AI in Medical Writing Market, By Value, In USD Million, 2018-2032F
Figure 115. Middle East & Africa AI in Medical Writing Market Share (%), By Type, 2018-2032F
Figure 116. Middle East & Africa AI in Medical Writing Market Share (%), By Deployment Mode, 2018-2032F
Figure 117. Middle East & Africa AI in Medical Writing Market Share (%), By End-use, 2018-2032F
Figure 118. Middle East & Africa AI in Medical Writing Market Share (%), By Country, 2018-2032F
Figure 119. Saudi Arabia AI in Medical Writing Market, By Value, In USD Million, 2018-2032F
Figure 120. Saudi Arabia AI in Medical Writing Market Share (%), By Type, 2018-2032F
Figure 121. Saudi Arabia AI in Medical Writing Market Share (%), By Deployment Mode, 2018-2032F
Figure 122. Saudi Arabia AI in Medical Writing Market Share (%), By End-use, 2018-2032F
Figure 123. UAE AI in Medical Writing Market, By Value, In USD Million, 2018-2032F
Figure 124. UAE AI in Medical Writing Market Share (%), By Type, 2018-2032F
Figure 125. UAE AI in Medical Writing Market Share (%), By Deployment Mode, 2018-2032F
Figure 126. UAE AI in Medical Writing Market Share (%), By End-use, 2018-2032F
Figure 127. South Africa AI in Medical Writing Market, By Value, In USD Million, 2018-2032F
Figure 128. South Africa AI in Medical Writing Market Share (%), By Type, 2018-2032F
Figure 129. South Africa AI in Medical Writing Market Share (%), By Deployment Mode, 2018-2032F
Figure 130. South Africa AI in Medical Writing Market Share (%), By End-use, 2018-2032F
Figure 131. By Type Map-Market Size (USD Million) & Growth Rate (%), 2024
Figure 132. By Deployment Mode Map-Market Size (USD Million) & Growth Rate (%), 2024
Figure 133. By End-use Map-Market Size (USD Million) & Growth Rate (%), 2024
Figure 134. By Region Map-Market Size (USD Million) & Growth Rate (%), 2024

Product Code: MX13352

Global AI in medical writing market is projected to witness a CAGR of 11.61% during the forecast period 2025-2032, growing from USD 845.42 million in 2024 to USD 2035.05 million in 2032. The market's growth can be attributed to the increasing production of regulatory documents, scientific publications, and clinical studies, rising reliance on generative AI, and growing focus on the incorporation of new technologies in different healthcare processes to streamline repetitive tasks and reduce incidences of human error.

Regulatory authorities across the globe are gradually showing openness to AI-assisted documentation, provided that human review is maintained and audit trails are preserved. AI also ensures consistency across sections of a submission, helping teams maintain document integrity even when multiple authors are involved. The growing availability of AI platforms offering plug-and-play solutions for clinical documentation has accelerated adoption among mid-sized CROs and pharmaceutical companies that need to meet tight deadlines without expanding writing teams. By using AI tools that are integrated with electronic data capture (EDC) and trial master file (TMF) systems, companies can automate the flow of data from source to submission.

Due to the increasing awareness and acceptance of different AI tools in medical writing, AI companies across the globe are focusing on launching new models that offer research assistance and are transforming scientific content creation workflow. For instance, in November 2024, AINGENS, LLC introduced the Medical Affairs Content Generator (MACg), an AI-powered medical writing tool that provides citation support, editing, and reference management.

Increasing Investments in AI-Powered Solutions Bolster Market Growth

Substantial investments in AI technologies by pharmaceutical, biotech, and contract research organizations (CROs) are propelling the growth of the market. Companies are increasingly allocating budgets to deploy AI-based platforms that support medical writing, as part of broader digital transformation strategies. With the rising need for multilingual medical documentation and region-specific compliance requirements, global pharmaceutical companies are investing in AI systems capable of handling linguistic and regulatory diversity. Furthermore, AI-based automation enables scalable solutions that can handle the rising volume of documentation stemming from expanding pipelines and increasing post-marketing surveillance needs. The resulting efficiencies are fostering a culture of innovation in regulatory writing and increasing accessibility to medical writing support even among emerging biotech and pharmaceutical companies.

Leading AI companies across the globe are focusing on securing funding to support medical writers in keeping up with new drug launches. For instance, in November 2024, Biolevate raised approximately USD 6.8 million in seed funding to develop solutions that help medical writers keep pace with therapeutic product launches. Such launches are expected to reduce the administrative workload associated with the creation of documents for regulatory bodies, enhancing the efficiency of pharmaceutical professionals, thus providing lucrative growth opportunities for the market.

New Launches Support Market Expansion

Innovations and new launches are allowing biotech and pharmaceutical companies to effectively draft essential documents with the help of sophisticated AI technology. New technologies leverage machine learning and natural language processing to ensure compliance with regulatory standards, enhancing consistency and accuracy in medical content and minimizing human errors. The integration of AI tools is also able to address the increasing complexity of regulatory processes and clinical research, allowing companies to adapt to the digital transformation trends and the evolving requirements of the industry.

The key players in the market are focusing on launching new solutions for industrial applications. For instance, in February 2025, Indegene Inc. launched Cortex, a generative AI platform designed for the life science industry. The platform plays a crucial role in scaling and developing high-value life science applications, including improving the efficiency of medical writing and optimization of the content supply chain. By leveraging large language models, the platform delivers accurate and reliable results, with better ROI and faster turnaround times.

Clinical Writing Witnesses Fastest Growth

The increasing volume and complexity of clinical trial data along with the stringent regulatory requirements is propelling the requirement for consistent and accurate documentation. As of 23rd May 2025, 538,875 studies are registered at ClinicalTrials.gov, the publicly available registry and results database, that is run by the National Library of Medicine (NLM) at the National Institutes of Health (NIH).

AI tools are well-suited for addressing the rising requirements for automation of repetitive tasks including report generation and summarization, improving turnaround time, and reducing human error. Furthermore, advancements in machine learning and natural language processing are making AI tools more suitable for handling specialized language requirements of clinical writing. As healthcare and pharmaceutical companies across the globe recognize the benefits of AI in managing clinical documentation, including improved accuracy and efficiency and economic benefits, adoption rates are increasing, propelling the market's demand.

North America Holds Major Market Share

The region's dominance in the market can be attributed to the presence of a favorable regulatory environment, strong presence of pharmaceutical companies, and easy acceptance of new technologies. Health Canada and the United States Food and Drug Administration (FDA) are both acknowledging the potential of AI in medical writing and healthcare documentation, supporting the market's expansion in the region.

Furthermore, the increasing shortage of skilled medical writers in the region is encouraging companies to actively invest in AI and launch now AI-integrated solutions to tackle complex documents and manage the increased workload. For instance, in July 2024, InSilico Medicine launched DORA, an AI assistant for drafting research papers. The AI assistant uses large language models to draft case studies and academic papers, in addition to patents and grants. Such launches are expected to boost productivity and reduce barriers for research professionals with limited resources.

Future Market Scenario (2025-2032F)

The market is expected to witness strong growth opportunities in the coming years owing to the rising complexity of regulatory frameworks and the increasing volume of clinical data. Advancements in generative AI and language models are expected to improve the narrative quality and contextual understanding of AI-written documents. Leading market players are focusing on launching domain-specific AI solutions that cater to diverse therapeutic areas. Furthermore, regulatory bodies across the globe are working on introducing new guidelines for the ethical use of AI in medical writing. Over the period, AI tools are anticipated to not only support content generation but also aid in optimizing submission strategies, ensuring standardization in global documentation processes.

Key Players Landscape and Outlook

The key players in the market are focusing on technological innovations and the integration of generative AI with their regulatory writing software. For instance, in June 2024, Certara, Inc. launched its CoAuthor regulatory writing software for medical writers. The software combines structured content authoring tools, document templates, and generative AI to accelerate the creation of regulatory documents. Such innovations are improving quality, consistency, and efficiency in medical writing by reducing drafting time. This integration allows Certara to strengthen its position in the market by allowing scientists and healthcare professionals to manage regulatory demands and tackle increasing data complexities, thus providing lucrative growth opportunities for the market.

1. Project Scope and Definitions

2. Research Methodology

3. Impact of U.S. Tariffs

4. Executive Summary

5. Global AI in Medical Writing Market Outlook, 2018-2032F

5.1. Market Size Analysis & Forecast
- 5.1.1. By Value
5.2. Market Share Analysis & Forecast
- 5.2.1. By Type
  - 5.2.1.1. Clinical Writing
  - 5.2.1.2. Regulatory Writing
  - 5.2.1.3. Patient Documentation
  - 5.2.1.4. Scientific Writing
- 5.2.2. By Deployment Mode
  - 5.2.2.1. On-premises
  - 5.2.2.2. Cloud-based
- 5.2.3. By End-use
  - 5.2.3.1. Medical Device Companies
  - 5.2.3.2. Pharmaceutical and Biotechnology Companies
  - 5.2.3.3. Academic and Research Institutions
  - 5.2.3.4. Others
- 5.2.4. By Region
  - 5.2.4.1. North America
  - 5.2.4.2. Europe
  - 5.2.4.3. Asia-Pacific
  - 5.2.4.4. South America
  - 5.2.4.5. Middle East and Africa
- 5.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
5.3. Market Map Analysis, 2024
- 5.3.1. By Type
- 5.3.2. By Deployment Mode
- 5.3.3. By End-use
- 5.3.4. By Region

6. North America AI in Medical Writing Market Outlook, 2018-2032F

6.1. Market Size Analysis & Forecast
- 6.1.1. By Value
6.2. Market Share Analysis & Forecast
- 6.2.1. By Type
  - 6.2.1.1. Clinical Writing
  - 6.2.1.2. Regulatory Writing
  - 6.2.1.3. Patient Documentation
  - 6.2.1.4. Scientific Writing
- 6.2.2. By Deployment Mode
  - 6.2.2.1. On-premises
  - 6.2.2.2. Cloud-based
- 6.2.3. By End-use
  - 6.2.3.1. Medical Device Companies
  - 6.2.3.2. Pharmaceutical and Biotechnology Companies
  - 6.2.3.3. Academic and Research Institutions
  - 6.2.3.4. Others
- 6.2.4. By Country Share
  - 6.2.4.1. United States
  - 6.2.4.2. Canada
  - 6.2.4.3. Mexico
6.3. Country Market Assessment
- 6.3.1. United States AI in Medical Writing Market Outlook, 2018-2032F*
  - 6.3.1.1. Market Size Analysis & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share Analysis & Forecast
    - 6.3.1.2.1. By Type
      - 6.3.1.2.1.1. Clinical Writing
      - 6.3.1.2.1.2. Regulatory Writing
      - 6.3.1.2.1.3. Patient Documentation
      - 6.3.1.2.1.4. Scientific Writing
    - 6.3.1.2.2. By Deployment Mode
      - 6.3.1.2.2.1. On-premises
      - 6.3.1.2.2.2. Cloud-based
    - 6.3.1.2.3. By End-use
      - 6.3.1.2.3.1. Medical Device Companies
      - 6.3.1.2.3.2. Pharmaceutical and Biotechnology Companies
      - 6.3.1.2.3.3. Academic and Research Institutions
      - 6.3.1.2.3.4. Others
- 6.3.2. Canada
- 6.3.3. Mexico

All segments will be provided for all regions and countries covered

7. Europe AI in Medical Writing Market Outlook, 2018-2032F

7.1. Germany
7.2. France
7.3. Italy
7.4. United Kingdom
7.5. Russia
7.6. Netherlands
7.7. Spain
7.8. Turkey
7.9. Poland

8. Asia-Pacific AI in Medical Writing Market Outlook, 2018-2032F

8.1. India
8.2. China
8.3. Japan
8.4. Australia
8.5. Vietnam
8.6. South Korea
8.7. Indonesia
8.8. Philippines

9. South America AI in Medical Writing Market Outlook, 2018-2032F

9.1. Brazil
9.2. Argentina

10. Middle East and Africa AI in Medical Writing Market Outlook, 2018-2032F

10.1. Saudi Arabia
10.2. UAE
10.3. South Africa

11. Demand Supply Analysis

12. Porter's Five Forces Analysis

13. PESTLE Analysis

14. Pricing Analysis

15. Market Dynamics

15.1. Market Drivers
15.2. Market Challenges

16. Market Trends and Developments

17. Technological Advancements and Innovation

18. Case Studies

19. Competitive Landscape

19.1. Competition Matrix of Top 5 Market Leaders
19.2. SWOT Analysis for Top 5 Players
19.3. Key Players Landscape for Top 10 Market Players
- 19.3.1. Indegene Inc.
  - 19.3.1.1. Company Details
  - 19.3.1.2. Key Management Personnel
  - 19.3.1.3. Products and Services
  - 19.3.1.4. Financials (As Reported)
  - 19.3.1.5. Key Market Focus and Geographical Presence
  - 19.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
- 19.3.2. Suki AI, Inc.
- 19.3.3. Certara, Inc.
- 19.3.4. Abridge Al, Inc.
- 19.3.5. Freyr Software Services Pvt Ltd
- 19.3.6. IQVIA Inc.
- 19.3.7. GENINVO
- 19.3.8. Teladoc Health, Inc.
- 19.3.9. TrialAssure
- 19.3.10. Yseop S.A.S

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

メディカルライティング向けAIの世界市場：種類別・展開方式別・最終用途別・地域別の評価、機会と予測 (2018～2032年)

Global AI in Medical Writing Market Assessment, By Type, By Deployment Mode, By End-use, By Region, Opportunities and Forecast, 2018-2032F

目次

第1章 プロジェクトの範囲と定義

第2章 分析手法

第3章 米国の関税の影響

第4章 エグゼクティブサマリー

第5章 世界のメディカルライティング向けAI市場の将来展望 (2018～2032年)

第6章 北米のメディカルライティング向けAI市場の将来展望 (2018～2032年)

第7章 欧州のメディカルライティング向けAI市場の将来展望 (2018～2032年)

第8章 アジア太平洋のメディカルライティング向けAI市場の将来展望 (2018～2032年)

第9章 南米のメディカルライティング向けAI市場の将来展望 (2018～2032年)

第10章 中東・アフリカのメディカルライティング向けAI市場の将来展望 (2018～2032年)

第11章 需要・供給分析

第12章 ポーターのファイブフォース分析